Innova Captab

{
  "main_header": {
    "sid": 10039112,
    "name": "Innova Captab",
    "stock_name": "Innova Captab",
    "full_name": "Innova Captab Ltd",
    "name_url": "stocks-analysis/innova-captab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "706.55",
    "chg": -1,
    "chgp": "-0.14%",
    "dir": -1,
    "prev_price": "707.55",
    "mcapval": "3,988.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544067",
    "symbol": "INNOVACAP",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0DUT01020",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "14.41 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/innova-captab-10039112-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3820454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_mojoScore_3820454.png",
        "date": "2026-02-04 10:10:04",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Innova Captab Ltd Shows Mild Recovery Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-shows-mild-recovery-amid-mixed-technical-signals-3817324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/InnovaCaptabLtd_technicaldot_3817324.png",
        "date": "2026-02-03 08:05:41",
        "description": "Innova Captab Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day change of 0.10%, the stock’s technical indicators reveal a complex picture of price momentum and trend signals that investors should carefully analyse amid broader market conditions."
      },
      {
        "title": "Innova Captab Ltd Reports Strong Quarterly Turnaround Amid Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-reports-strong-quarterly-turnaround-amid-challenging-market-conditions-3804868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/InnovaCaptabLtd_fintrenddot_3804868.png",
        "date": "2026-01-27 08:00:24",
        "description": "Innova Captab Ltd has delivered a remarkable turnaround in its financial performance for the quarter ended December 2025, reversing a negative trend seen over recent months. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics, signalling a positive shift in operational momentum despite lingering challenges in return ratios and long-term stock performance."
      },
      {
        "title": "Innova Captab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/innova-captab-ltd-is-rated-sell-3803154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/InnovaCaptabLtd_mojoScore_3803154.png",
        "date": "2026-01-24 10:10:03",
        "description": "Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Innova Captab Gains 0.65%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-gains-065-4-key-factors-driving-the-weeks-volatility-3802855",
        "imagepath": "",
        "date": "2026-01-24 10:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 19:</strong> Stock hits 52-week low of Rs.625 amid downtrend</p>\n                    <p><strong>Jan 19:</strong> Intraday high surge of 7.14% to Rs.739.35</p>\n                    <p><strong>Jan 23:</strong> Intraday high with 12.48% surge to Rs.730</p>\n                    <p><strong>Jan 23:</strong> Q3 FY26 results show strong revenue growth but margin pressures</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.649.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.678.40</div><d..."
      },
      {
        "title": "Are Innova Captab Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-innova-captab-ltd-latest-results-good-or-bad-3802480",
        "imagepath": "",
        "date": "2026-01-23 19:18:08",
        "description": "Innova Captab Ltd's latest financial results for Q3 FY26 present a complex picture marked by significant topline growth alongside operational challenges. The company reported a net profit of ₹42.15 crores, reflecting a substantial recovery from the previous quarter, with a notable 42.06% increase quarter-on-quarter. Revenue also saw robust growth, reaching ₹450.29 crores, which represents an 18.38% increase from the prior quarter and a remarkable 42.29% year-on-year surge. This performance highlights the company's strong market traction and ability to drive sales.\n\nHowever, despite the impressive revenue figures, operational margins have come under pressure. The operating margin improved sequentially to 15.41%, recovering from 13.63% in the previous quarter, yet it remains below the peak of 15.63% recorded in Q2 FY24. The profit after tax (PAT) margin also saw a sequential improvement but contracted year-on..."
      },
      {
        "title": "Innova Captab Q3 FY26: Strong Revenue Surge Masks Margin Pressures and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/innova-captab-q3-fy26-strong-revenue-surge-masks-margin-pressures-and-valuation-concerns-3802385",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/InnovaCaptab_quaterlyResult_3802385.png",
        "date": "2026-01-23 17:48:09",
        "description": "Innova Captab Ltd. reported a robust quarter-on-quarter profit surge in Q3 FY26, with net profit jumping 42.06% to ₹42.15 crores compared to ₹29.67 crores in Q2 FY26. However, the Mumbai-based pharmaceutical manufacturer's shares remain under pressure, trading at ₹678.50 with a market capitalisation of ₹3,740 crores, down 36.64% over the past year despite posting a 23.25% year-on-year profit increase. The company's stellar revenue growth of 42.29% YoY to ₹450.29 crores in Q3 FY26 has been overshadowed by margin compression concerns and elevated valuation multiples."
      },
      {
        "title": "Innova Captab Ltd Hits Intraday High with 12.48% Surge on 23 Jan 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-hits-intraday-high-with-1248-surge-on-23-jan-2026-3801883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/InnovaCaptabLtd_priceRelatedfactors_3801883.png",
        "date": "2026-01-23 13:17:46",
        "description": "Innova Captab Ltd recorded a robust intraday performance on 23 Jan 2026, surging to a day’s high of Rs 730, marking an 11.12% increase. The stock outperformed its Pharmaceuticals & Biotechnology sector peers and the broader market, registering a notable 12.48% gain by close of trading."
      },
      {
        "title": "Innova Captab Ltd Falls to 52-Week Low of Rs.625 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/innova-captab-ltd-falls-to-52-week-low-of-rs625-amid-continued-downtrend-3794783",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/InnovaCaptabLtd_priceRelatedfactors_3794783.png",
        "date": "2026-01-19 15:42:28",
        "description": "Innova Captab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.625 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics."
      }
    ],
    "total": 487,
    "sid": "10039112",
    "stock_news_url": "https://www.marketsmojo.com/news/innova-captab-10039112"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Feb-2026",
      "details": "Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Pursuant to Regulation 30 read with Schedule III (Part A) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the officials of the Company will be attending the Investor Conference as per the details provided in intimation.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "02-Feb-2026",
      "details": "Transcript of the Investor/Analyst Earnings Call held on 27th January 2026: This is in continuation to our letter dated 27th January 2026 wherein we had informed regarding the audio link of the earnings call with analysts/investors for the quarter and nine months ended 31st December 2025.The transcript will be available on the Companys website.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "02-Feb-2026",
      "details": "Transcript of the Investor/Analyst Earnings Call held on 27th January 2026: This is in continuation to our letter dated 27th January 2026 wherein we had informed regarding the audio link of the earnings call with analysts/investors for the quarter and nine months ended 31st December 2025.The transcript will be available on the Companys website.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Innova Captab Ltd has declared <strong>20%</strong> dividend, ex-date: 30 Jan 26",
          "dt": "2026-01-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Innova Captab Ltd is Rated Sell

2026-02-04 10:10:04

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Innova Captab Ltd Shows Mild Recovery Amid Mixed Technical Signals

2026-02-03 08:05:41

Innova Captab Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a modest day change of 0.10%, the stock’s technical indicators reveal a complex picture of price momentum and trend signals that investors should carefully analyse amid broader market conditions.

Read full news article

Innova Captab Ltd Reports Strong Quarterly Turnaround Amid Challenging Market Conditions

2026-01-27 08:00:24

Innova Captab Ltd has delivered a remarkable turnaround in its financial performance for the quarter ended December 2025, reversing a negative trend seen over recent months. The pharmaceutical and biotechnology company posted record quarterly figures across key metrics, signalling a positive shift in operational momentum despite lingering challenges in return ratios and long-term stock performance.

Read full news article

Innova Captab Ltd is Rated Sell

2026-01-24 10:10:03

Innova Captab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Innova Captab Gains 0.65%: 4 Key Factors Driving the Week’s Volatility

2026-01-24 10:00:06

Key Events This Week

Jan 19: Stock hits 52-week low of Rs.625 amid downtrend

Jan 19: Intraday high surge of 7.14% to Rs.739.35

Jan 23: Intraday high with 12.48% surge to Rs.730

Jan 23: Q3 FY26 results show strong revenue growth but margin pressures

Week Open

Rs.649.20

Week Close

Rs.678.40

Read full news article

Are Innova Captab Ltd latest results good or bad?

2026-01-23 19:18:08

Innova Captab Ltd's latest financial results for Q3 FY26 present a complex picture marked by significant topline growth alongside operational challenges. The company reported a net profit of ₹42.15 crores, reflecting a substantial recovery from the previous quarter, with a notable 42.06% increase quarter-on-quarter. Revenue also saw robust growth, reaching ₹450.29 crores, which represents an 18.38% increase from the prior quarter and a remarkable 42.29% year-on-year surge. This performance highlights the company's strong market traction and ability to drive sales. However, despite the impressive revenue figures, operational margins have come under pressure. The operating margin improved sequentially to 15.41%, recovering from 13.63% in the previous quarter, yet it remains below the peak of 15.63% recorded in Q2 FY24. The profit after tax (PAT) margin also saw a sequential improvement but contracted year-on...

Read full news article

Innova Captab Q3 FY26: Strong Revenue Surge Masks Margin Pressures and Valuation Concerns

2026-01-23 17:48:09

Innova Captab Ltd. reported a robust quarter-on-quarter profit surge in Q3 FY26, with net profit jumping 42.06% to ₹42.15 crores compared to ₹29.67 crores in Q2 FY26. However, the Mumbai-based pharmaceutical manufacturer's shares remain under pressure, trading at ₹678.50 with a market capitalisation of ₹3,740 crores, down 36.64% over the past year despite posting a 23.25% year-on-year profit increase. The company's stellar revenue growth of 42.29% YoY to ₹450.29 crores in Q3 FY26 has been overshadowed by margin compression concerns and elevated valuation multiples.

Read full news article

Innova Captab Ltd Hits Intraday High with 12.48% Surge on 23 Jan 2026

2026-01-23 13:17:46

Innova Captab Ltd recorded a robust intraday performance on 23 Jan 2026, surging to a day’s high of Rs 730, marking an 11.12% increase. The stock outperformed its Pharmaceuticals & Biotechnology sector peers and the broader market, registering a notable 12.48% gain by close of trading.

Read full news article

Innova Captab Ltd Falls to 52-Week Low of Rs.625 Amid Continued Downtrend

2026-01-19 15:42:28

Innova Captab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.625 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.

Read full news article

View All News